We provide comprehensive drug supply, manufacturing, and lab support, led by experts in European regulations to ensure pipeline excellence
Developing ATMPs: from Lab to Clinic
In this new episode of Exploring and Bringing Advanced Therapies Closer, we will briefly learn how to lay the foundations and plan the development of advanced therapy medicinal products (ATMPs) so that they can reach clinical practice.
Introducing Advanthed Therapies.
In this new episode of "Exploring and Bringing Advanced Therapies Closer," we will learn about the development of Advanced Therapy Medicinal Products (ATMPs) at the European level—how these consortia work, the requirements set by the European Union, and the challenges we may face.
We will conclude by exploring a developing project, the TriAnkle project for tissue regeneration through bioprinting as a therapy for patients with osteoarthritis: 3D printing with biocompatible materials.
All of this with Eva Martin Becerra, an expert in innovation management and technology transfer, including coordination of European projects.
European Projects: A Case Study
In this new episode of Exploring and Bringing Advanced Therapies Closer, we will learn about the development of advanced therapy medicinal products (ATMPs) at the European level—how these consortia work, what the European Union's requirements are, and the challenges we may encounter.We will also get to know an example of an ongoing project: the TriAnkle project, which focuses on tissue regeneration through bioprinting as a therapy for patients with osteoarthritis, using 3D printing with biocompatible materials.
All of this will be presented by Eva Martin Becerra, an expert in innovation management and technology transfer, including the coordination of European projects.